Get notified of page updates
Education > XRAY > Ovarian Cancer

FORCE's eXamining the Relevance of Articles for You (XRAY) program looks behind the headlines of cancer news to help you understand what the research means for you. XRAY is a reliable source of hereditary cancer research-related news and information.
Learn more about the XRAY program

How To Use XRAY
Search by Topic Submit an Article for Review

Ovarian Cancer

41 through 50 of 79

Relevance: High

Strength of Science: High

Research Timeline: Post Approval

Study : Second surgery may not benefit women with recurrent ovarian cancer

Relevance: High

Strength of Science: High

Research Timeline: Post Approval

Most relevant for: Women with recurrent ovarian cancer

Many women who have recurrent ovarian cancer have a second surgery. A new study suggests that women with platinum sensitive cancers who get chemotherapy alone may do as well as or better than women who have surgery followed by chemotherapy. (1/21/20)

Read More

Relevance: High

Strength of Science: High

Research Timeline: Human Research

View Related Clinical Trials

Study : Niraparib increases progression-free survival in patients with newly diagnosed ovarian cancer

Relevance: High

Strength of Science: High

Research Timeline: Human Research

View Related Clinical Trials

Most relevant for: Women newly-diagnosed with ovarian cancer

This study looked at the effectiveness and safety of niraparib (Zejula), a PARP inhibitor, as maintenance therapy in newly diagnosed ovarian cancer patients who had a response to chemotherapy. (11/5/19)

Read More

Relevance: High

Strength of Science: Medium

View Related Clinical Trials

Study : Supportive care can improve quality of life for people with metastatic breast cancer

Relevance: High

Strength of Science: Medium

View Related Clinical Trials

Most relevant for: People diagnosed with metastatic breast cancer

Metastatic breast cancer patients have unique needs for treatment and care. Connecting patients to appropriate support services and palliative care is an area of need in health care. A recent study reported improvement in metastatic breast cancer patient quality of life and wellness with an intervention program called the Supportive, Education and Advocacy (MBC-SEA) program. (8/21/19)

Read More

Relevance: Medium-High

Strength of Science: High

Research Timeline: Post Approval

View Related Clinical Trials

Study : LGBTQ patients recommend improvements for their cancer care

Relevance: Medium-High

Strength of Science: High

Research Timeline: Post Approval

View Related Clinical Trials

Most relevant for: LGBTQ cancer patients and their healthcare providers.

Very little research has focused on the cancer care experiences of lesbian, gay, bisexual, transgender and queer (LGBTQ) people. This study looks at recommendations from the LGBTQ community for improving their cancer care. (6/20/19)

Read More

Relevance: Medium-High

Strength of Science: Medium-High

Research Timeline: Post Approval

Study : Prevalence of BRCA founder mutations in Bahamian women

Relevance: Medium-High

Strength of Science: Medium-High

Research Timeline: Post Approval

Most relevant for: Bahamanian women

The Bahamas has the highest known frequency of BRCA mutations among people diagnosed with breast cancer. This study reviewed whether population-based BRCA testing (testing everyone regardless of family or personal history of cancer) would be an effective approach for finding mutation carriers in the Bahamas. (3/4/19)

Read More

Relevance: Low

Research Timeline: Lab Research

View Related Clinical Trials

Article : Promise of a cure for cancer is too good to be true

Relevance: Low

Research Timeline: Lab Research

View Related Clinical Trials

Most relevant for: People diagnosed with cancer

The Jerusalem Post published an article titled, “A cure for cancer?  Israeli scientists may have found one.” The story profiled a small Israeli company called Accelerated Evolution Biotechnologies that has been working on developing new cancer treatments since 2000. The article relied almost entirely on an interview with the company’s chairperson of the board who made a series of unsubstantiated claims that included that, in a year’s time, the company will offer a complete cure for cancer. (2/12/19)

Read More

Relevance: High

Quality of Writing: High

View Related Clinical Trials

Article : The cost of cancer care and impact of financial hardship on treatment

Relevance: High

Quality of Writing: High

View Related Clinical Trials

Most relevant for: Anyone diagnosed with cancer

Several recent studies on the cost of cancer care show the negative effects on cancer patients. We review an article by Kaiser Health News and associated studies about the financial impact of breast cancer treatment and cost of precision medicine. (2/8/19)

Read More

Relevance: High

Strength of Science: High

Research Timeline: Post Approval

View Related Clinical Trials

Study : Can population-based DNA sequencing find more people at risk for hereditary cancers?

Relevance: High

Strength of Science: High

Research Timeline: Post Approval

View Related Clinical Trials

Most relevant for: Women over age 30

It is well documented that many BRCA mutation carriers are missed using current family history-based screening approaches. As a result, experts are beginning to call for population-based BRCA genetic testing—an organized effort to screen all women like we do for breast and cervical cancer.  A recent study looked at whether a population-based genetic testing approach would better identify mutation carriers compared with current practice. (11/17/18)

Read More

Relevance: High

Quality of Writing: High

View Related Clinical Trials

Article : The importance of racial diversity in clinical trials

Relevance: High

Quality of Writing: High

View Related Clinical Trials

Most relevant for: People who are a member of a racial or ethnic minority group

This article by journalists Caroline Chen and Riley Wong looks at racial disparities between participation in clinical trials and the population of people with cancer. (11/6/18)

Este artículo está disponible en español.

Read More

Relevance: Medium-Low

Strength of Science: Medium

Research Timeline: Human Research

View Related Clinical Trials

Study : A new method for determining whether genetic variants in BRCA1 increase cancer risk

Relevance: Medium-Low

Strength of Science: Medium

Research Timeline: Human Research

View Related Clinical Trials

Most relevant for: People who have a Variant of Uncertain Significance in a gene associated with cancer risk.

Ever since BRCA1 was discovered, researchers have been trying to understand which of the thousands of possible DNA changes in this gene increase cancer risk and which are harmless changes.  A new study in Nature reports how a cutting-edge technology called “genome editing” may be used to classify changes—known as variants of uncertain significance-in BRCA1 as harmful or harmless. Once validated, this same technology may be used to classify variants in other genes. (9/29/18)

Read More

This Portal Sponsored By:

AstraZeneca